1. Home
  2. CASH vs PVLA Comparison

CASH vs PVLA Comparison

Compare CASH & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$90.27

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$118.50

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
PVLA
Founded
1954
2015
Country
United States
United States
Employees
N/A
14
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CASH
PVLA
Price
$90.27
$118.50
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$96.33
$161.13
AVG Volume (30 Days)
221.5K
335.3K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
0.22%
N/A
EPS Growth
18.88
N/A
EPS
1.57
N/A
Revenue
$839,894,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$6.02
N/A
P/E Ratio
$57.89
N/A
Revenue Growth
11.29
N/A
52 Week Low
$64.45
$18.23
52 Week High
$96.06
$151.18

Technical Indicators

Market Signals
Indicator
CASH
PVLA
Relative Strength Index (RSI) 51.17 50.50
Support Level $87.09 $85.53
Resistance Level $95.58 $147.47
Average True Range (ATR) 2.71 9.02
MACD -0.49 -2.70
Stochastic Oscillator 46.77 7.27

Price Performance

Historical Comparison
CASH
PVLA

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: